Abstract: A method for the treatment for hepatitis delta infection in a host, that includes administering an effective amount of a nucleoside or a nucleoside analog that suppresses the expression of the hepatitis B surface or preS1 antigen in the host 100-fold or more relative to pretreatment values in vivo; or to not more than 1 microgram per milliliter in vivo. In a preferred embodiment, the nucleoside is L-FMAU, or a pharmaceutically acceptable salt or prodrug thereof.

Abstract: A method for the treatment for hepatitis delta infection in a host, that includes administering an effective amount of a nucleoside or a nucleoside analog that suppresses the expression of the hepatitis B surface or preS1 antigen in the host 100-fold or more relative to pretreatment values in vivo; or to not more than 1 microgram per milliliter in vivo. In a preferred embodiment, the nucleoside is L-FMAU, or a pharmaceutically acceptable salt or prodrug thereof.

Abstract: A method for the treatment for hepatitis delta infection in a host, that includes administering an effective amount of a nucleoside or a nucleoside analog that suppresses the expression of the hepatitis B surface or preS1 antigen in the host 100-fold or more relative to pretreatment values in vivo; or to not more than 1 microgram per milliliter in vivo. In a preferred embodiment, the nucleoside is L-FMAU, or a pharmaceutically acceptable salt or prodrug thereof.

Abstract: The present invention is an improved indicia reader which, in addition to having magnetically encoded information reading capabilities in one embodiment, includes image sensing capabilities. A compact housing is provided which receives an indicia bearing member. Mounted on the housing in one embodiment are an imaging assembly, and a magnetically encoded information reader, which form an indicia-determining unit, and a transport mechanism for transporting the indicia-determining unit and a received member relative to one another. The reader may further includes a data format engine in communication with the indicia-determining unit.

Abstract: A method for the treatment for hepatitis delta infection in a host, that includes administering an effective amount of a nucleoside or a nucleoside analog that suppresses the expression of the hepatitis B surface or preS1 antigen in the host 100-fold or more relative to pretreatment values in vivo; or to not more than 1 microgram per milliliter in vivo. In a preferred embodiment, the nucleoside is L-FMAU, or a pharmaceutically acceptable salt or prodrug thereof.

Abstract: The present invention is an improved check reader which, in addition to having magnetic ink character recognition capabilities, includes image sensing capabilities. A compact housing is provided which receives a document. Mounted on the housing are an imaging assembly, and a magnetic ink character reader, which form an indicia-determining unit, and a transport mechanism for transporting the indicia-determining unit and a received document relative to one another. The check reader further includes a data format engine in communication with the indicia-determining unit. When a document and the indicia-determining unit are transported relative to one another, the data-format engine captures a first electronic representation of indicia formed on the received document, and a second electronic representation of magnetic ink indicia on the received document.

Abstract: Automatic means and methods for hyphenating words suitable for use with digitally controlled printing apparatus wherein the consonant-vowel pattern of a predetermined selected portion of a word is converted to binary digital values and compared to a compact table of consonant-vowel pattern values. Certain exception conditions may be separately handled to increase accuracy.